J. Lagrange

发表

70 Gy versus 80 Gy in localized prostate cancer: 5-year results of GETUG 06 randomized trial.

P. Maingon, B. Dubray, N. Salem, 2011, International journal of radiation oncology, biology, physics.

Nomograms to predict late urinary toxicity after prostate cancer radiotherapy

T. Messai, R. Crevoisier, B. Dubray, 2013, World Journal of Urology.

Random forests to predict rectal toxicity following prostate cancer radiation therapy.

J. C. Correa, B. Dubray, O. Acosta, 2014, International journal of radiation oncology, biology, physics.

Identification of a rectal subregion highly predictive of rectal bleeding in prostate cancer IMRT.

Pascal Haigron, Caroline Lafond, Antoine Simon, 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[Radiotherapy of bone metastases].

J. Thariat, J. Lagrange, A. Leysalle, 2013, Bulletin du cancer.

Thyroid carcinomas after irradiation for a first cancer during childhood.

M. Schlumberger, N. Daly-Schveitzer, J. Zucker, 1999, Archives of internal medicine.

Development and use of a computer system in a radiotherapy department: SISGRAD.

M. Héry, S. Marcié, P. Chauvel, 1987, International journal of radiation oncology, biology, physics.

Radiation-induced CD8 T-lymphocyte Apoptosis as a Predictor of Breast Fibrosis After Radiotherapy: Results of the Prospective Multicenter French Trial☆

Sébastien Clippe, Christophe Hennequin, André Pèlegrin, 2015, EBioMedicine.

RILA blood biomarker as a predictor of radiation-induced sarcoma in a matched cohort study☆

F. Collin, P. Maingon, J. Thariat, 2019, EBioMedicine.

Impact of adjuvant hormonotherapy on radiation-induced breast fibrosis according to the individual radiosensitivity: results of a multicenter prospective French trial

C. Bourgier, C. Hennequin, F. Mornex, 2018, Oncotarget.

Sequence-dependent effects of ZD1839 (‘Iressa’) in combination with cytotoxic treatment in human head and neck cancer

G Milano, N. Magné, A. Dubreuil, 2002, British Journal of Cancer.

Concomitant b.i.d. radiotherapy and chemotherapy with cisplatin and 5-fluorouracil in unresectable squamous-cell carcinoma of the pharynx: clinical and pharmacological data of a French multicenter phase II study.

G. Poissonnet, P. Marcy, O. Dassonville, 1998, International journal of radiation oncology, biology, physics.

Image-guided radiation therapy for muscle-invasive bladder cancer

M. Housset, J. Thariat, P. Marcy, 2012, Nature Reviews Urology.

Localized adenocarcinoma of the lung: a retrospective study of 186 non-metastatic patients from the French Federation of Cancer Institutes--the Radiotherapy Cooperative Group.

B. Castelain, L. Malissard, J. Lagrange, 1991, International journal of radiation oncology, biology, physics.

[Population study of dihydropyrimidine dehydrogenase in cancer patients].

O. Dassonville, F. Demard, G. Milano, 1994, Bulletin du cancer.

Dose escalation with 3D-CRT in prostate cancer: French study of dose escalation with conformal 3D radiotherapy in prostate cancer-preliminary results.

P. Maingon, S. Marcié, D. Cowen, 2000, International journal of radiation oncology, biology, physics.

Summary report of the Standards, Options and Recommendations for the management of patients with non-small-cell lung carcinoma (2000)

E. Touboul, T. Molina, E. Lemarié, 2003, British Journal of Cancer.

Image-guided Radiation Therapy (IGRT) in Prostate Cancer: Preliminary Results in Prostate Registration and Acute Toxicity of a Randomized Study

R. Crevoisier, J. Bachaud, A. Laplanche, 2009 .

[Long-term results of exclusive radiotherapy and brachytherapy of breast cancer].

J. Lagrange, Y. Otmezguine, E. Calitchi, 2012, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

The Prognostic Value of Eight Comorbidity Indices in Older Patients with Cancer: The ELCAPA Cohort Study

C. Tournigand, E. Audureau, J. Lagrange, 2022, Cancers.

Oxaliplatin–5-Fluorouracil and Ionizing Radiation

N. Magné, A. Dubreuil, S. Marcié, 2003, Oncology.

Radiotherapy for a solitary brain metastasis during pregnancy: a method for reducing fetal dose.

N. Magné, S. Marcié, J. Pignol, 2001, The British journal of radiology.

Results of a randomized clinical trial comparing two radiation schedules in the palliative treatment of brain metastases.

C. Haie-meder, R. Arriagada, A. Laplanche, 1993, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Impact of 18F-fluoro-2-deoxyglucose positron emission tomography on treatment strategy and radiotherapy planning for stage I-II Hodgkin disease: a prospective multicenter study.

P. Bondiau, F. Giammarile, S. Chabaud, 2011, International journal of radiation oncology, biology, physics.

Effect of Adding Docetaxel to Androgen-Deprivation Therapy in Patients With High-Risk Prostate Cancer With Rising Prostate-Specific Antigen Levels After Primary Local Therapy: A Randomized Clinical Trial

A. Ravaud, S. Culine, G. Deplanque, 2019, JAMA oncology.

Do minitransplants have minicosts? A cost comparison between myeloablative and nonmyeloablative allogeneic stem cell transplant in patients with acute myeloid leukemia

I. Durand-zaleski, H. Esperou, C. Cordonnier, 2005, Bone Marrow Transplantation.

Dose-intensity of a four-drug chemotherapy regimen with or without recombinant human granulocyte-macrophage colony-stimulating factor in extensive-stage small-cell lung cancer: a multicenter randomized phase III study.

B. Milleron, D. Spaeth, J. Pujol, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Brain metastases of lung cancer: excessive toxicity of high dose VP 16 213.

J. Lagrange, A. Thyss, M. Frénay, 1988, European journal of cancer & clinical oncology.

Optimal management of elderly cancer patients: usefulness of the Comprehensive Geriatric Assessment

S. Culine, J. Lagrange, S. Bastuji‐Garin, 2014, Clinical interventions in aging.

[Radiotherapy of bone metastases].

S. Thureau, J. Lagrange, S. Supiot, 2016, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Geriatric assessment findings independently associated with clinical depression in 1092 older patients with cancer: the ELCAPA Cohort Study

C. Tournigand, C. Lemogne, J. Lagrange, 2016, Psycho-oncology.

Nine breast angiosarcomas after conservative treatment for breast carcinoma: a survey from French comprehensive Cancer Centers.

B. Weber, J. Lagrange, H. Mignotte, 1999, International journal of radiation oncology, biology, physics.

International radiation oncology trainee decision making in the management of radiotherapy-induced nausea and vomiting

Liying Zhang, B. Corn, C. Wong, 2013, Supportive Care in Cancer.

Pharmacokinetics of cisplatin given at a daily low dose as a radiosensitiser

A. Courdi, G. Milano, P. Chauvel, 2004, Cancer Chemotherapy and Pharmacology.

Adjuvant radiotherapy for extremity and trunk wall atypical lipomatous tumor/well-differentiated LPS (ALT/WD-LPS): a French Sarcoma Group (GSF-GETO) study.

S. Bonvalot, J. Coindre, S. Leyvraz, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

[Repeated radiation dose effect and DNA repair: Importance of the individual factor and the time interval between the doses].

A. Puisieux, T. Lacornerie, E. Lartigau, 2016, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Pulmonary toxicity of a combination of low-dose doxorubicin and irradiation for inoperable lung cancer.

M. Namer, J. Pinto, J. Lagrange, 1987, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Cisplatin Nephrotoxicity: A Multivariate Analysis of Potential Predisposing Factors

X. Pivot, G. Milano, J. Ferrero, 1997, Pharmacotherapy.

The clinical pathologic analysis of radiotherapy for cutaneous B-cell lymphoma

J. Lagrange, Liang-ming Zhang, Xiao-wei Wang, 2008 .

Small cell lung cancer: patients surviving longer than thirty months. Groupe d'oncologie de langue française.

B. Milleron, E. Brambilla, D. Moro, 1994, Anticancer research.

Radiotherapy and chemotherapy for invasive thymomas: a multicentric retrospective review of 90 cases. The FNCLCC trialists. Fédération Nationale des Centres de Lutte Contre le Cancer.

P. Rambert, F. Mornex, X. Mirabel, 1995, International journal of radiation oncology, biology, physics.

European French-speaking study from the GEMO group on bone metastases management: a special focus on external beam radiotherapy practice survey

N. Magné, Cyrus Chargari, R. Mirimanoff, 2011, Supportive Care in Cancer.

Importance of the irradiation timing within a chemoradiotherapy sequence including cisplatin and 5-FU-folinic acid. Experimental results.

G. Milano, J. Fischel, P. Formento, 1993, European journal of cancer.

Quality of life assessment after concurrent chemoradiation for invasive bladder cancer: results of a multicenter prospective study (GETUG 97-015).

C. Bascoul-Mollevi, J. Bachaud, F. Joly, 2011, International journal of radiation oncology, biology, physics.

Early Toxicity of a Phase 2 Trial of Combined Salvage Radiation Therapy and Hormone Therapy in Oligometastatic Pelvic Node Relapses of Prostate Cancer (OLIGOPELVIS GETUG P07).

F. Denis, D. Pasquier, V. Beckendorf, 2019, International journal of radiation oncology, biology, physics.

[Trends in radiation therapy for the treatment of metastatic and oligometastatic disease in 2010].

J. Thariat, P. Marcy, J. Lagrange, 2010, Bulletin du cancer.

Non-specifically labelled cells that simulate bone marrow metastases in patients with non-metastatic breast cancer.

M. Namer, J. Ferrero, J. Lagrange, 1997, Journal of clinical pathology.

Marked fluctuations in drug plasma concentrations caused by use of portable pumps for fluorouracil continuous infusion.

G. Milano, J. Lagrange, A. Thyss, 1993, Journal of the National Cancer Institute.

What Do Older Adults Know About Their Cancer Diagnosis and Treatment? The ELCAPA‐08 Cohort Study

C. Tournigand, J. Lagrange, S. Bastuji‐Garin, 2016, Journal of the American Geriatrics Society.

[Normal tissue tolerance to external beam radiation therapy: bone marrow].

J. Lagrange, F. Drouet, 2010, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Cytotoxic effects of long-term circulating ultrafiltrable platinum species and limited efficacy of haemodialysis in clearing them.

G. Milano, J. Fischel, P. Formento, 1994, European journal of cancer.

[State of the art and advances in radiotherapy for bladder cancer].

P. Bondiau, M. Housset, J. Thariat, 2009, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

Toxicity of a combination of ABVD chemotherapy and mediastinal irradiation for Hodgkin's disease patients with massive initial mediastinal involvement.

M. Héry, J. Lagrange, A. Thyss, 1988, Bulletin du cancer.

Definition of lymph node areas for radiotherapy of prostate cancer: A critical literature review by the French Genito-Urinary Group and the French Association of Urology (GETUG-AFU).

S. Guérif, R. de Crevoisier, C. Hennequin, 2015, Cancer treatment reviews.

Prostate Cancer: A Retrospective Evaluation of Radiotherapy in French Cancer Institutes

M. Bolla, B. Castelain, M. Hay, 1991 .

Follicular mycosis fungoides: response to radiation therapy

J. Ortonne, J. Lacour, J. Lagrange, 1994, The British journal of dermatology.

The essential role of radiotherapy in the treatment of Merkel cell carcinoma: a study from the Rare Cancer Network.

R. Miralbell, J. Kaanders, D. Aebersold, 2011, International journal of radiation oncology, biology, physics.

Anal canal carcinoma: early-stage tumors < or =10 mm (T1 or Tis): therapeutic options and original pattern of local failure after radiotherapy.

E. Touboul, A. Ramaioli, D. Peiffert, 2005, International journal of radiation oncology, biology, physics.

Sarcoma after radiation therapy: retrospective multiinstitutional study of 80 histologically confirmed cases. Radiation Therapist and Pathologist Groups of the Fédération Nationale des Centres de Lutte Contre le Cancer.

J. Coindre, A. Ramaioli, P. Rambert, 2000, Radiology.

Not all sarcomas developed in irradiated tissue are necessarily radiation-induced--spectrum of disease and treatment characteristics.

A. Italiano, J. Thariat, P. Marcy, 2012, Critical reviews in oncology/hematology.

Protection of testes during radiation treatment by irregular and focused fields of 25 MV x-rays: in vivo evaluation of the absorbed dose.

S. Marcié, J. Lagrange, A. Costa, 1995, Medical dosimetry : official journal of the American Association of Medical Dosimetrists.

Adjuvant radiotherapy for extremity and trunk wall atypical lipomatous tumor/well-differentiated LPS (ALT/WD-LPS): a French Sarcoma Group (GSF-GETO) study.

J. Blay, S. Bonvalot, J. Coindre, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Long-term results of breast cancer irradiation treatment with low-dose-rate external irradiation.

M. Tubiana, J. Lagrange, Y. Otmezguine, 2007, International journal of radiation oncology, biology, physics.

Second malignant neoplasms after a first cancer in childhood: temporal pattern of risk according to type of treatment

F. Eschwège, N. Daly-Schveitzer, J. Zucker, 1999, British Journal of Cancer.

OLIGOPELVIS GETUG P07, a Multicenter Phase II Trial of Combined High-dose Salvage Radiotherapy and Hormone Therapy in Oligorecurrent Pelvic Node Relapses in Prostate Cancer.

N. Magné, D. Peiffert, F. Denis, 2021, European urology.

Short-term androgen deprivation therapy combined with radiotherapy as salvage treatment after radical prostatectomy for prostate cancer (GETUG-AFU 16): a 112-month follow-up of a phase 3, randomised trial.

N. Magné, B. Dubray, D. Peiffert, 2019, The Lancet. Oncology.

Is There a Role for Pelvic Irradiation in Localized Prostate Adenocarcinoma? Update of the Long-Term Survival Results of the GETUG-01 Randomized Study.

D. Pérol, S. Chabaud, V. Beckendorf, 2016, International journal of radiation oncology, biology, physics.

Androgen deprivation therapy plus docetaxel and estramustine versus androgen deprivation therapy alone for high-risk localised prostate cancer (GETUG 12): a phase 3 randomised controlled trial.

A. Ravaud, S. Culine, G. Deplanque, 2015, The Lancet. Oncology.

Fractionated total body irradiation and bone marrow transplantation in acute lymphoblastic leukemia.

D. Blaise, D. Maraninchi, J. Lagrange, 1990, International journal of radiation oncology, biology, physics.

Radiation dose, chemotherapy and risk of soft tissue sarcoma after solid tumours during childhood

G. Vassal, N. Daly-Schveitzer, J. Zucker, 2004, International journal of cancer.

Salvage radiotherapy with or without short-term hormone therapy for rising prostate-specific antigen concentration after radical prostatectomy (GETUG-AFU 16): a randomised, multicentre, open-label phase 3 trial.

B. Dubray, S. Guérif, A. Ruffion, 2016, The Lancet. Oncology.

A phase III trial of docetaxel-estramustine in high-risk localised prostate cancer: a planned analysis of response, toxicity and quality of life in the GETUG 12 trial.

A. Ravaud, S. Culine, G. Deplanque, 2012, European journal of cancer.

Oligopelvis-GETUG P07: A multicenter phase II trial of combined salvage radiotherapy and hormone therapy in oligorecurrent pelvic node relapses of prostate cancer.

N. Magné, F. Denis, D. Pasquier, 2020 .

In vivo fusion of circulating fluorescent cells with dystrophin-deficient myofibers results in extensive sarcoplasmic fluorescence expression but limited dystrophin sarcolemmal expression.

F. Chrétien, C. Christov, R. Gherardi, 2005, The American journal of pathology.

Introducing a prognostic score for pretherapeutic assessment of seminal vesicle invasion in patients with clinically localized prostate cancer.

R. Porcher, C. Abbou, A. Hoznek, 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Common strategy for adult and pediatric medulloblastoma: a multicenter series of 253 adults.

C. Haie-meder, D. Frappaz, D. Cowen, 2007, International journal of radiation oncology, biology, physics.

[Postoperative radiotherapy of prostate cancer].

L. Salomon, P. François, A. García, 2014, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Radiation dose, chemotherapy and risk of osteosarcoma after solid tumours during childhood

G. Vassal, F. Eschwège, J. Zucker, 1998, International journal of cancer.

Assessment of solid cancer treatment feasibility in older patients: a prospective cohort study.

C. Tournigand, S. Culine, O. Beauchet, 2014, The oncologist.

Non-Hodgkin's lymphoma of the testis: a retrospective study of 84 patients treated in the French anticancer centres.

A. Ramaioli, P. Biron, C. Théodore, 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

Cardiac metastases. Case report on an isolated cardiac metastasis of a myxoid liposarcoma

T. le Chevalier, G. Contesso, J. Lagrange, 1986, Cancer.

Influence of Nucleoshuttling of the ATM Protein in the Healthy Tissues Response to Radiation Therapy: Toward a Molecular Classification of Human Radiosensitivity.

J. Bourhis, D. Stoppa-Lyonnet, A. Puisieux, 2016, International journal of radiation oncology, biology, physics.

Stereotactic radiation therapy in the strategy of treatment of metastatic renal cell carcinoma: A study of the Getug group.

G. Calais, J. Habrand, R. de Crevoisier, 2018, European journal of cancer.

[White paper on radiation oncology in France. Twelve proposals to improve a major cancer treatment. Société française de radiothérapie oncologique].

I. Barillot, J. Ferlay, C. de Martel, 2013, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Impact of targeting deviations on outcome in medulloblastoma: study of the French Society of Pediatric Oncology (SFOP).

J. Habrand, F. Doz, J. Lagrange, 1999, International journal of radiation oncology, biology, physics.

Is there a role for pelvic irradiation in localized prostate adenocarcinoma? Preliminary results of GETUG-01.

Sylvie Chabaud, Pascal Pommier, N. Voirin, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Waiting times before initiation of radiotherapy might not affect outcomes for patients with glioblastoma: a French retrospective analysis of patients treated in the era of concomitant temozolomide and radiotherapy

R. Crevoisier, P. Bondiau, X. Durando, 2012, Journal of Neuro-Oncology.

Performance of Four Frailty Classifications in Older Patients With Cancer: Prospective Elderly Cancer Patients Cohort Study.

C. Tournigand, J. Droz, E. Audureau, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[Radiation recall dermatitis after docetaxel and external beam radiotherapy. Report of two cases and review of the literature].

N. Magné, M. Namer, K. Bénézery, 2002, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Review of current best practice and priorities for research in radiation oncology for elderly patients with cancer: the International Society of Geriatric Oncology (SIOG) task force.

P. Koper, R. Audisio, I. Kunkler, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Thymoma: results of a multicentric retrospective series of 149 non-metastatic irradiated patients and review of the literature. FNCLCC trialists. Fédération Nationale des Centres de Lutte Contre le Cancer.

D. Cowen, P. Rambert, F. Mornex, 1995, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Quality control of radiotherapeutic treatment of medulloblastoma in a multicentric study: the contribution of radiotherapy technique to tumour relapse. The French Medulloblastoma Group.

J. Lagrange, C. Carrie, D. Pontvert, 1992, Radiotherapy and Oncology.

Solitary meningeal plasmacytomas.

S. Chanalet, P. Paquis, J. Lagrange, 1997, Annals of oncology : official journal of the European Society for Medical Oncology.

PERATIVE ABSTRACTS of the XX PTCOG MEETING held in Chester , England May 16-18 1994

F., N. Bornfeld, F. Demard, 2008 .

Predictors of 1-Year Mortality in a Prospective Cohort of Elderly Patients With Cancer.

C. Tournigand, J. Lagrange, S. Bastuji‐Garin, 2015, The journals of gerontology. Series A, Biological sciences and medical sciences.

Malignant breast tumors after radiotherapy for a first cancer during childhood.

M. Mathieu, N. Daly-Schveitzer, J. Zucker, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Predicting Frailty and Geriatric Interventions in Older Cancer Patients: Performance of Two Screening Tools for Seven Frailty Definitions—ELCAPA Cohort

E. Audureau, J. Lagrange, S. Bastuji‐Garin, 2022, Cancers.

[X-ray computed tomography in surveillance of colorectal cancers treated by radical surgery].

C. Balu-Maestro, F. Ettore, J. Lagrange, 1988, Journal de radiologie.

International patterns of practice in the management of radiation therapy-induced nausea and vomiting.

Liying Zhang, Y. M. van der Linden, B. Corn, 2012, International journal of radiation oncology, biology, physics.

Summary of the Standards, Options and Recommendations for the management of patients with nonmetastatic prostate cancer (2001)

A. Villers, B. Fervers, A. Bataillard, 2003, British Journal of Cancer.

Daily Versus Weekly Prostate Cancer Image Guided Radiation Therapy: Phase 3 Multicenter Randomized Trial.

J. Bachaud, R. de Crevoisier, M. Bayar, 2018, International journal of radiation oncology, biology, physics.

A controlled study of postoperative radiotherapy for patients with completely resected nonsmall cell lung carcinoma

R. Arriagada, B. Dautzenberg, C. Chastang, 1999, Cancer.

[Prostate radiation therapy: in vivo measurement of the dose delivered by kV-CBCT].

J. Lagrange, G. Marinello, J. Mège, 2009, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Invasive lobular carcinoma of the breast: MRI pathological correlation following bilateral total mastectomy

A. Luciani, A. Rahmouni, J. Lagrange, 2012, Acta radiologica.

Does short-term androgen depletion add to high-dose radiotherapy (80 Gy) in localized intermediate-risk prostate cancer? Intermediary analysis of GETUG 14 randomized trial (EU-20503/NCT00104741).

B. Dubray, J. Bachaud, S. Guérif, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Changes in sexual function after radiotherapy treatment of prostate cancer.

V. Beckendorf, M. Hay, J. Lagrange, 1996, British journal of urology.

[Image-guided radiotherapy].

A. Isambert, M. Marguet, R. de Crevoisier, 2007, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Assessment of “squamous cell carcinoma antigen” (SCC) as a marker of epidermoid carcinoma of the anal canal

M. Namer, P. Chauvel, J. Lagrange, 1991, Diseases of the colon and rectum.

Very long-term complete remission can be achieved in men with high-risk localized prostate cancer and a very high PSA value: an analysis of the GETUG 12 Phase 3 trial

S. Culine, D. Drubay, G. Deplanque, 2023, Clinical Genitourinary Cancer.

Nomograms to predict late urinary toxicity after prostate cancer radiotherapy

R. Crevoisier, B. Dubray, O. Acosta, 2013, World Journal of Urology.

[Neoplasms induced by radiotherapy for prostate cancer: report of a case of pelvic sarcoma and review of the literature].

C. Abbou, A. De la taille, P. Sèbe, 2004, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

Population study of dihydropyrimidine dehydrogenase in cancer patients.

F Demard, G Milano, O. Dassonville, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Tumoral platinum concentrations in patients treated with repeated low‐dose cisplatin as a radiosensitizer

P. Bondiau, G. Milano, P. Chauvel, 1996 .

Quality-of-life (QOL) assessment after concurrent chemoradiation for invasive bladder cancer. Preliminary results of a French multicenter prospective study

J. Bachaud, F. Joly, A. Kramar, 2003 .

Cost of prostate image-guided radiation therapy: results of a randomized trial.

J. Bachaud, M. Morelle, R. de Crevoisier, 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[Prostate cancer: what treatment techniques for which tumors? Ethical and methodological issues].

R. Crevoisier, S. Guérif, J. Castelli, 2014, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Energy expenditure profiles and the risk of early limiting toxicity in older patients with cancer: The ELCAPA-25 prospective cohort survey.

C. Tournigand, S. Culine, M. Loriot, 2022, Clinical nutrition.

Role of radiotherapy in the treatment of invasive lymphoepithelial thymomas. A multicentric retrospective review of 89 cases

P. Rambert, F. Mornex, X. Mirabel, 1993 .

Mediastinal irradiation in patients with esophageal carcinoma after heart transplantation

J. Lagrange, Y. Kirova, C. Locher, 2003, Cancer.

Acute cardiac effects of mediastinal irradiation: assessment by radionuclide angiography.

O. Migneco, J. Darcourt, J. Benoliel, 1992, International journal of radiation oncology, biology, physics.

CT measurement of lung density: the role of patient position and value for total body irradiation.

M. Héry, N. Brassard, J. Lagrange, 1987, International journal of radiation oncology, biology, physics.

Granulocytic sarcoma with meningeal leukemia but no bone marrow involvement at presentation. A report of two cases with characteristic cerebrospinal fluid cytology.

J. Lagrange, M. Gaspard, A. Thyss, 1992, Acta cytologica.

Four Distinct Health Profiles in Older Patients With Cancer: Latent Class Analysis of the Prospective ELCAPA Cohort.

C. Tournigand, E. Audureau, J. Lagrange, 2016, The journals of gerontology. Series A, Biological sciences and medical sciences.

Daily versus weekly prostate cancer image-guided radiotherapy: A phase 3, multicenter, randomized trial.

R. Crevoisier, J. Bachaud, M. Bayar, 2018 .

[Ductal carcinoma in situ: role of the boost].

I. Barillot, P. Maingon, A. Monnier, 2008, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Ex vivo MRI of axillary lymph nodes in breast cancer.

A. Luciani, F. Ghozali, A. Rahmouni, 2009, European journal of radiology.

[Standards, Options and Recommendations for the management of non-small cell lung carcinoma patients].

E. Touboul, T. Molina, E. Lemarié, 2003, Bulletin du cancer.

[Standards, options and recommendations for the management of locally advanced non small cell lung carcinoma].

E. Touboul, E. Lemarié, B. Milleron, 2001, Bulletin du cancer.

Establishment of two new human bladder carcinoma cell lines, CAL 29 and CAL 185. Comparative study of cell scattering and epithelial to mesenchyme transition induced by growth factors

B. Mari, C. Chauzy, B. Rossi, 2001, British Journal of Cancer.

[Image-guided radiotherapy: rational, modalities and results].

C. Lafond, R. de Crevoisier, G. Cazoulat, 2009, Bulletin du cancer.

Review of current best practice and priorities for research in radiation oncology for elderly patients with cancer: the International Society of Geriatric Oncology (SIOG) task force.

P. Koper, R. Audisio, I. Kunkler, 2014, Annals of Oncology.

[Reappraisal of the role of endobronchial brachytherapy in the management of lung cancer: ten years' experience at the centre Antoine-Lacassagne].

N. Magné, S. Marcié, P. Marcy, 2003, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

[Ethical stakes in palliative care in radiation oncology].

R. de Crevoisier, S. Thureau, A. Escande, 2021, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

[Target-volume and critical-organ delineation for conformal radiotherapy of prostate cancer: experience of French dose-escalation trials].

P. Maingon, D. Cowen, J. Bachaud, 2002, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

[Intraprostatic calcifications as natural fiducial markers in image-guided radiotherapy for prostate cancer].

J. Thariat, N. Tachfouti, J. Lagrange, 2014, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

[Advances in radiation oncology for metastatic bone disease].

J. Thariat, R. Bensadoun, J. Lagrange, 2013, Bulletin du cancer.

[Radiotherapy of bone metastases].

J. Thariat, J. Lagrange, A. Leysalle, 2013, Bulletin du cancer.

Influence of Nucleoshuttling of the ATM Protein in the Healthy Tissues Response to Radiation Therapy: Toward a Molecular Classification of Human Radiosensitivity.

J. Bourhis, D. Stoppa-Lyonnet, A. Puisieux, 2016, International journal of radiation oncology, biology, physics.